Clinical practice and metabolic consequences of olanzapine use in schizophrenia: results from a national survey in Spain L.I. Muñoz-Manchado; M. Bernardo; J.M. Villagrán-Moreno; E. Fernández-Egea;

Spanish validation of ¿The Awareness of Social Inference Test¿ (TASIT) Lorena García-Fernández; Nuria Cabot-Ivorra; Verónica Romero-Ferreiro; Miguel A. Álvarez-Mon; Estela Jiménez López; Guillermo Lahera; Skye McDonald; Roberto Rodriguez-Jimenez;

Functional brain imaging of negative symptoms in schizophrenia: further evidence of prefrontal dysfunction Paola Fuentes-Claramonte; Ana Aquino-Servín; María Ángeles Garcia-León; Jordi Ortiz-Gil; Pilar Salgado-Pineda; Amalia Guerrero-Pedraza; Salvador Sarró; Emilio J. Inarejos-Clemente; Raymond Salvador; Peter J. McKenna; Edith Pomarol-Clotet;